Soliman H, Hogue D, Han HS, Mooney B, et al. A phase 1 trial of talimogene laherparepvec in combination with neoadjuvant chemotherapy for the treatment of non-metastatic triple-negative breast cancer. Clin Cancer Res 2020 Nov 20. pii: 1078-0432.CCR-20-3105.
PMID: 33219014